
51 - 200 employees
Founded 2017
🧬 Biotechnology
🏥 Healthcare
💊 Pharmaceuticals
Biotechnology • Healthcare • Pharmaceuticals
Cabaletta Bio is a clinical-stage biotechnology company developing engineered T cell therapies to treat autoimmune diseases. Using its CABA® (Cabaletta Approach to B cell Ablation) platform, the company is advancing rese-cel, a fully human CD19 CAR T cell candidate with a 4-1BB co-stimulatory domain, in multiple RESET™ Phase 1/2 trials for systemic lupus erythematosus, myositis, systemic sclerosis, generalized myasthenia gravis, and pemphigus vulgaris. Cabaletta aims to deliver deep, durable, potentially curative responses by transiently eliminating B cells to reset immune tolerance, and emphasizes patient-centered development and broad indication expansion across rheumatology, dermatology, and neurology.
🕒 September 1
Improve your chances of getting an interview by checking your resume score before you apply.

51 - 200 employees
Founded 2017
🧬 Biotechnology
🏥 Healthcare
💊 Pharmaceuticals
Biotechnology • Healthcare • Pharmaceuticals
Cabaletta Bio is a clinical-stage biotechnology company developing engineered T cell therapies to treat autoimmune diseases. Using its CABA® (Cabaletta Approach to B cell Ablation) platform, the company is advancing rese-cel, a fully human CD19 CAR T cell candidate with a 4-1BB co-stimulatory domain, in multiple RESET™ Phase 1/2 trials for systemic lupus erythematosus, myositis, systemic sclerosis, generalized myasthenia gravis, and pemphigus vulgaris. Cabaletta aims to deliver deep, durable, potentially curative responses by transiently eliminating B cells to reset immune tolerance, and emphasizes patient-centered development and broad indication expansion across rheumatology, dermatology, and neurology.
• Serve as the primary technical expert for the design, qualification, and technology transfer of clinical and commercial label, artwork, and packaging configurations across the global CDMO network • Ensure robust chain of identity (COI) and chain of custody (COC) • Develop and standardize patient-specific labeling strategies across CMOs, clinical sites, depots, and logistics providers • Oversee consistent labeling execution without direct operational ownership • Define standards for label readability, human factors, and required data elements • Ensure label performance under cryogenic, condensation, and transport conditions • Review packaging specifications, labeling content, and artwork for accuracy and compliance • Own SOPs, specifications, and governance, including change control, deviations/CAPAs, and reconciliation/destruction oversight • Ensure labeling meets global regulatory requirements and support IND/BLA filings and inspections • Establish validation strategies for 21 CFR Part 11 and GMP compliance • Review and approve IQ/OQ/PQ and vendor validation documentation • Design, qualify, and validate patient-specific, temperature-controlled packaging systems • Ensure packaging supports vein-to-vein logistics timing constraints • Manage container closure integrity and compatibility with cryogenic storage and handling • Perform risk assessments for packaging failures impacting patient material • Support scale-up network expansion, new CMOs, new regions, and the clinical-to-commercial transition • Perform other related duties as assigned
• Bachelor's degree or equivalent (preferred concentration in Engineering, Supply Chain, Packaging Science, or a related field) • 5–7 years of experience in labeling, packaging, or artwork management within biopharmaceutical, cell therapy, or regulated GMP manufacturing environments • Relevant experience in autologous cell & gene therapy is ideal • Working knowledge of FDA, EMA, and Annex 13 labeling requirements • Experience supporting IND/BLA filings preferred • Experience with 21 CFR Part 11, GMP, and validation practices (IQ/OQ/PQ) • Familiarity with cryogenic or cold-chain packaging and patient-specific (autologous) cell therapy supply chains strongly preferred • Ability to manage cross-functional relationships and external vendor/CMO oversight without direct operational authority • Strong project management, documentation, and change-control skills
• Competitive benefits • PTO • Stock option plans
Apply Now🕒 September 1
Senior Quality Manager leading regulated quality technology, digital transformation, and QMS governance for medical device manufacturer Integer. Developing global teams and ensuring FDA-compliant technology adoption.
🇺🇸 United States – Remote
💵 $128.3k - $188.1k / year
💰 Post-IPO Debt on 2023-01
⏰ Full Time
🟠 Senior
👔 Manager
🕒 September 1
Managing Thomson Reuters’ Global Trade professional services team and enterprise software implementations. Driving client delivery, sales support, upsells, and revenue.
🇺🇸 United States – Remote
💵 $100.1k - $185.9k / year
⏰ Full Time
🟠 Senior
🔴 Lead
👔 Manager
🦅 H1B Visa Sponsor
🕒 September 1
Federal Services leader building Paragon Micro’s cleared IT delivery organization for U.S. Federal Government customers. Scaling professional services, staffing, managed services, partnerships, and profitable growth.
🕒 September 1
District Manager driving Yuengling beer sales, distribution, and merchandising across Virginia. Managing wholesalers, retailers, budgets, pricing, and market execution for America’s oldest brewery.
🕒 September 1
Onboarding and support manager helping US machine shops adopt CloudNC’s AI CAM software. Owning customer implementation, product support, escalations, and scalable onboarding systems.
🇺🇸 United States – Remote
💰 Convertible Note - CloudNC on 2024-11
⏰ Full Time
🟡 Mid-level
🟠 Senior
👔 Manager